<em>ESR1</em> Mutations in Primary Breast Cancer
Suzanne A. W. Fuqua, PhD, professor of medicine at Baylor College of Medicine, discusses ESR1 mutations in primary breast cancer.
Clinical Pearls
Suzanne A. W. Fuqua, PhD, professor of medicine at Baylor College of Medicine, discussesESR1mutations in primary breast cancer.
- There is some controversy surrounding whether or notESR1mutations are associated with primary breast cancer.
- It has been reported that the K303R mutation was present in premalignant breast cancer as well as in primary breast tumors.
- Further research is needed to validate the presence and frequency of the K303R mutation in primary breast cancer.
Related Videos
Related Content
Sequencing Sacituzumab and Other Drugs in HR+, HER2- Breast Cancer
May 16th 2024Article
During a Case-Based Roundtable® event, Stephanie L. Graff, MD, discussed multiple later-line treatment options in hormone receptor–positive breast cancer with participants in the first article of a 2-part series.
Read More
